ReviewEULAR rheumatology open2025
Vitamin D supplementation: still a challenge for rheumatologists!
Review in EULAR rheumatology open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
There is consensus around vitamin D in patients with osteoporosis: considerable data have shown that vitamin D may be favourable in the elderly because of a positive effect on bone health and muscle strength. However, in the field of rheumatology, there are still unresolved items: (i) low vitamin D levels are associated with higher disease activity in patients with inflammatory arthritis (rheumatoid arthritis [RA], systemic lupus erythematosus [SLE], spondyloarthritis [SpA], and psoriatic arthritis [PsA]) and (ii) vitamin D supplementation (2000 IU/d) seems to reduce the risk of new inflammatory diseases. We discussed these data because they are new and relevant for rheumatologists in their daily practice, and the potential favourable effects of higher dosages of vitamin D in patients with inflammatory arthritis should be high on the research agenda.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.